Edition:
United States

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

39.07EUR
11:35am EDT
Change (% chg)

€0.61 (+1.59%)
Prev Close
€38.46
Open
€38.50
Day's High
€39.16
Day's Low
€38.46
Volume
446,212
Avg. Vol
534,335
52-wk High
€39.16
52-wk Low
€24.55

Latest Key Developments (Source: Significant Developments)

Recordati: European Commission approves Reagila as schizophrenia treatment
Wednesday, 19 Jul 2017 04:12am EDT 

July 19 (Reuters) - RECORDATI SPA ::EUROPEAN COMMISSION APPROVES REAGILA (CARIPRAZINE) FOR TREATMENT OF SCHIZOPHRENIA.  Full Article

Recordati signs license agreement with Richter to commercialize cariprazine
Tuesday, 2 Aug 2016 02:00am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Signs a license agreement with Gedeon Richter (Richter) to commercialize cariprazine in Western Europe and in Algeria, in Tunisia and in Turkey . The European Medicines Agency (EMA) started the evaluation of Richter's marketing authorization application for cariprazine, an atypical antipsychotic, for the treatment of schizophrenia in March . Recordati to make an upfront payment and further milestone payments depending on the progress of both the regulatory procedure and the product commercialization . Further sales-related royalties will become payable to Richter following the launch of the product .Richter to be responsible for conducting pediatric clinical studies according to the Pediatric Investigation Plan, as required by the European Medicines Agency's PDCO (Pediatric Committee) and it shall be co-financed with Recordati.  Full Article

Recordati H1 net profit jumps at EUR 122.7 mln
Thursday, 28 Jul 2016 06:05am EDT 

Recordati Industria Chimica E Farmaceutica SpA : H1 net profit 122.7 million euros ($136.07 million) versus 103.2 million euros a year ago, up 18.9 percent .H1 net revenues 587.9 million euros versus 539.1 million euros a year ago, up 9.1 percent.  Full Article

Recordati buys 100 pct stake in Swiss pharmaceutical company Pro Farma
Thursday, 14 Jul 2016 06:31am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Announces acquisition of 100 percent of share capital of Pro Farma AG, a swiss pharmaceutical company .Value of transaction (enterprise value) is of 16 million Swiss francs ($16.31 million) and will be funded from existing liquidity.  Full Article

Italy's Recordati buys Italchimici in deal valued at 130 mln euros
Tuesday, 31 May 2016 10:05am EDT 

Italy's Recordati Industria Chimica E Farmaceutica says: has bought all of Italian pharmaceutical company Italchimici . deal valued at about 130 million euros .to be funded in cash.  Full Article

Recordati Industria Chimica E Farmaceutica SpA proposes dividend on 2015 of 0.60 euros per share
Tuesday, 8 Mar 2016 08:04am EST 

Recordati Industria Chimica E Farmaceutica SpA:Proposes dividend on 2015 of 0.60 euro per share, of which 0.30 euro already paid.  Full Article

Recordati Industria Chimica e Farmaceutica SpA confirms FY 2015 outlook in line with analysts' estimates, proposes interim 2015 dividend
Wednesday, 28 Oct 2015 07:21am EDT 

Recordati Industria Chimica e Farmaceutica SpA:Confirms to achieve FY 2015 sales of around 1.04 billion euros.Confirms FY 2015 operating income of around 270 million euros.Confirms FY 2015 net income of around 190 million euros.Reported FY 2014 revenue at 987.4 million euros.Reported FY 2014 operating profit at 231.0 million euros.Reported FY 2014 net profit of 161.2 million euros.FY 2015 revenue of 1.04 billion euros - Thomson Reuters I/B/E/S.FY 2015 operating profit of 273.1 million euros - Thomson Reuters I/B/E/S.FY 2015 net profit of 193.9 million euros - Thomson Reuters I/B/E/S.Proposes 2015 interim dividend of 0.30 euros per share.  Full Article